Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,467 | 311 | 98.2% |
| Education | $99.95 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,107 | 67 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $839.17 | 32 | $0 (2023) |
| PFIZER INC. | $803.43 | 62 | $0 (2023) |
| GlaxoSmithKline, LLC. | $520.84 | 28 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $384.66 | 20 | $0 (2024) |
| Allergan, Inc. | $304.45 | 23 | $0 (2020) |
| Astellas Pharma US Inc | $272.14 | 10 | $0 (2019) |
| Merck Sharp & Dohme LLC | $257.54 | 16 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $217.86 | 11 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $173.89 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $326.59 | 15 | ABBVIE INC. ($131.92) |
| 2023 | $425.09 | 22 | AbbVie Inc. ($214.35) |
| 2022 | $609.26 | 34 | ABBVIE INC. ($287.66) |
| 2021 | $1,297 | 72 | AbbVie Inc. ($472.80) |
| 2020 | $798.23 | 43 | PFIZER INC. ($207.83) |
| 2019 | $899.62 | 39 | SANOFI-AVENTIS U.S. LLC ($293.85) |
| 2018 | $516.87 | 39 | PFIZER INC. ($140.36) |
| 2017 | $694.55 | 48 | PFIZER INC. ($213.45) |
All Payment Transactions
312 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Respiratory | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Respiratory | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 364 | 1,338 | $332,700 | $102,624 |
| 2022 | 10 | 291 | 1,107 | $274,086 | $78,687 |
| 2021 | 8 | 331 | 1,256 | $280,757 | $92,796 |
| 2020 | 11 | 465 | 1,666 | $363,518 | $119,177 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 504 | $126,079 | $36,432 | 28.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 37 | 218 | $69,299 | $20,062 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 128 | $30,464 | $13,111 | 43.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 32 | 137 | $33,148 | $8,887 | 26.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 53 | $24,565 | $6,338 | 25.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 86 | $8,600 | $4,827 | 56.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 50 | $9,000 | $3,560 | 39.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 34 | 44 | $11,616 | $3,212 | 27.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 17 | 22 | $10,358 | $2,709 | 26.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 22 | $7,621 | $2,417 | 31.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 14 | $1,050 | $563.42 | 53.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 41 | 60 | $900.00 | $504.00 | 56.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 50 | 497 | $122,220 | $33,277 | 27.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 32 | 179 | $57,018 | $14,888 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 86 | $20,468 | $8,801 | 43.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 31 | 108 | $26,080 | $6,631 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 78 | $14,040 | $6,079 | 43.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 32 | $15,041 | $4,130 | 27.5% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 15 | 21 | $9,559 | $2,451 | 25.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 27 | 31 | $7,755 | $2,079 | 26.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 36 | 62 | $930.00 | $183.63 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 13 | $975.00 | $167.86 | 17.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 84 | 851 | $182,799 | $58,001 | 31.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 62 | 71 | $28,229 | $9,057 | 32.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 73 | $17,374 | $7,971 | 45.9% |
About Dr. Mitchell Shear, MD
Dr. Mitchell Shear, MD is a Internal Medicine healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801952510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Shear, MD has received a total of $5,567 in payments from pharmaceutical and medical device companies, with $326.59 received in 2024. These payments were reported across 312 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,467).
As a Medicare-enrolled provider, Shear has provided services to 1,451 Medicare beneficiaries, totaling 5,367 services with total Medicare billing of $393,284. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location White Plains, NY
- Active Since 12/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1801952510
Products in Payments
- VRAYLAR (Drug) $1,267
- TRELEGY ELLIPTA (Drug) $520.84
- SOLIQUA 100/33 (Biological) $501.67
- CHANTIX (Drug) $443.17
- ELIQUIS (Drug) $307.51
- SOLIQUA 100/33 (Drug) $273.04
- XARELTO (Drug) $192.88
- XIFAXAN (Drug) $161.99
- JANUVIA (Drug) $128.37
- VIAGRA (Drug) $125.63
- FASENRA (Drug) $111.04
- STIOLTO RESPIMAT (Drug) $108.29
- Myrbetriq (Drug) $97.19
- FARXIGA (Drug) $93.64
- MYRBETRIQ (Drug) $75.00
- BELSOMRA (Drug) $67.42
- INJECTAFER (Drug) $63.83
- Otezla (Drug) $55.37
- EMGALITY (Drug) $54.96
- JARDIANCE (Drug) $51.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in White Plains
Tomrul Tuzel, M.d, M.D
Internal Medicine — Payments: $113,652
Dr. Sharon Parish, Md, MD
Internal Medicine — Payments: $74,824
Despoina Michailidou, Md, MD
Internal Medicine — Payments: $73,621
Daniel Wang, M.d, M.D
Internal Medicine — Payments: $19,656
Dr. Breta Boots, Do, DO
Internal Medicine — Payments: $9,255
Dr. Vivian Volterre, M.d, M.D
Internal Medicine — Payments: $7,003